{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T08:59:24Z","timestamp":1775293164505,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stent thrombosis (ST) is a fatal complication after percutaneous coronary intervention (PCI). The association between P2Y12 reaction unit (PRU) level and stent thrombosis occurrence remains unclear. Based on the multicenter, observational PTRG-DES (Platelet function and genoType-Related long-term proGnosis in DES-treated patients) registry of patients with drug-eluting stents (DES) implantation, a total of 11,714 patients with PRU values were analyzed. We sought to identify the predictors of early stent thrombosis (EST) and compared the primary outcome, a composite of cardiac death, myocardial infarction, and revascularization, between EST and non-EST groups. EST, defined as definite ST within 1\u00a0month after index PCI, occurred in 51 patients. PRU values were significantly higher in the EST group (263.5\u2009\u00b1\u200970.8 vs. 217.5\u2009\u00b1\u200978.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In multivariable analysis, PRU\u2009\u2265\u2009252 (OR, 5.10; 95% CI 1.58\u201316.46; <jats:italic>p<\/jats:italic>\u2009=\u20090.006) and aspirin reaction unit\u2009\u2265\u2009414 (OR 4.85; 95% CI 1.07\u201321.97; <jats:italic>p<\/jats:italic>\u2009=\u20090.040) were independent predictors of EST. The cumulative incidence of primary composite outcome at one year was significantly higher in the EST group (38.2% vs. 3.9%, Log-rank <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In patients treated with clopidogrel after successful DES implantation, EST was associated with higher platelet reactivities, and a greater risk of cardiovascular events.<\/jats:p><jats:p>Trial Registration: clinicaltrials.gov Identifier: NCT04734028.<\/jats:p>","DOI":"10.1038\/s41598-023-50920-9","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:03:15Z","timestamp":1704355395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation"],"prefix":"10.1038","volume":"14","author":[{"given":"Subin","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Jun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Joon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Joon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Woong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwhi","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Gyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yeub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Rae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moo Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PTRG Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Kuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Kwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Yeon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Woong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Young","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Ku","family":"Chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Hong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Gyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Jeong","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Sup","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seng Chan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"50920_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jjcc.2019.02.019","volume":"74","author":"MC Kim","year":"2019","unstructured":"Kim, M. C. et al. Incidence of cardiac death and recurrent stent thrombosis after treatment for angiographically confirmed stent thrombosis. J. Cardiol. 74, 267\u2013272. https:\/\/doi.org\/10.1016\/j.jjcc.2019.02.019 (2019).","journal-title":"J. Cardiol."},{"key":"50920_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.hlc.2019.10.009","volume":"29","author":"R Batchelor","year":"2020","unstructured":"Batchelor, R. et al. Incidence, predictors and clinical outcomes of stent thrombosis following percutaneous coronary intervention in contemporary practice. Heart Lung Circ. 29, 1433\u20131439. https:\/\/doi.org\/10.1016\/j.hlc.2019.10.009 (2020).","journal-title":"Heart Lung Circ."},{"key":"50920_CR3","doi-asserted-by":"publisher","first-page":"e023276","DOI":"10.1161\/jaha.121.023276","volume":"11","author":"T Ishihara","year":"2022","unstructured":"Ishihara, T. et al. Long-term outcomes and clinical predictors of mortality following occurrence of stent thrombosis. J. Am. Heart Assoc. 11, e023276. https:\/\/doi.org\/10.1161\/jaha.121.023276 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"50920_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1056\/NEJMoa0808227","volume":"360","author":"T Simon","year":"2009","unstructured":"Simon, T. et al. Genetic determinants of response to clopidogrel and cardiovascular events. N. Engl. J. Med. 360, 363\u2013375. https:\/\/doi.org\/10.1056\/NEJMoa0808227 (2009).","journal-title":"N. Engl. J. Med."},{"key":"50920_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3978\/j.issn.2223-3652.2013.02.06","volume":"3","author":"T Garabedian","year":"2013","unstructured":"Garabedian, T. & Alam, S. High residual platelet reactivity on clopidogrel: Its significance and therapeutic challenges overcoming clopidogrel resistance. Cardiovasc. Diagn. Ther. 3, 23\u201337. https:\/\/doi.org\/10.3978\/j.issn.2223-3652.2013.02.06 (2013).","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"50920_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3349\/ymj.2022.63.5.413","volume":"63","author":"AY Her","year":"2022","unstructured":"Her, A. Y. et al. Platelet function and genotype after DES implantation in east Asian patients: Rationale and characteristics of the PTRG-DES consortium. Yonsei Med. J. 63, 413\u2013421. https:\/\/doi.org\/10.3349\/ymj.2022.63.5.413 (2022).","journal-title":"Yonsei Med. J."},{"key":"50920_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s0140-6736(13)61170-8","volume":"382","author":"GW Stone","year":"2013","unstructured":"Stone, G. W. et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): A prospective multicentre registry study. Lancet 382, 614\u2013623. https:\/\/doi.org\/10.1016\/s0140-6736(13)61170-8 (2013).","journal-title":"Lancet"},{"key":"50920_CR8","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/circulationaha.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia, H. M. et al. Standardized end point definitions for coronary intervention trials: The academic research consortium-2 consensus document. Circulation 137, 2635\u20132650. https:\/\/doi.org\/10.1161\/circulationaha.117.029289 (2018).","journal-title":"Circulation"},{"key":"50920_CR9","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.jcin.2022.09.007","volume":"15","author":"SJ Lee","year":"2022","unstructured":"Lee, S. J. et al. Platelet reactivity and clinical outcomes after drug-eluting stent implantation: Results from the PTRG-DES consortium. JACC Cardiovasc. Interv. 15, 2253\u20132265. https:\/\/doi.org\/10.1016\/j.jcin.2022.09.007 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","volume":"6","author":"T Tada","year":"2013","unstructured":"Tada, T. et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients. JACC Cardiovasc. Interv. 6, 1267\u20131274. https:\/\/doi.org\/10.1016\/j.jcin.2013.06.015 (2013).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","volume":"14","author":"KH Chau","year":"2021","unstructured":"Chau, K. H. et al. Stent thrombosis risk over time on the basis of clinical presentation and platelet reactivity: Analysis From ADAPT-DES. JACC Cardiovasc. Interv. 14, 417\u2013427. https:\/\/doi.org\/10.1016\/j.jcin.2020.12.005 (2021).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijcard.2012.01.080","volume":"167","author":"F D'Ascenzo","year":"2013","unstructured":"D\u2019Ascenzo, F. et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int. J. Cardiol. 167, 575\u2013584. https:\/\/doi.org\/10.1016\/j.ijcard.2012.01.080 (2013).","journal-title":"Int. J. Cardiol."},{"key":"50920_CR13","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","volume":"46","author":"PA Gurbel","year":"2005","unstructured":"Gurbel, P. A. et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis: Results of the CREST Study. J. Am. Coll. Cardiol. 46, 1827\u20131832. https:\/\/doi.org\/10.1016\/j.jacc.2005.07.056 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50920_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.amjcard.2009.04.015","volume":"104","author":"TL Pinto Slottow","year":"2009","unstructured":"Pinto Slottow, T. L. et al. Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis. Am. J. Cardiol. 104, 525\u2013530. https:\/\/doi.org\/10.1016\/j.amjcard.2009.04.015 (2009).","journal-title":"Am. J. Cardiol."},{"key":"50920_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2011.1529","volume":"306","author":"G Cayla","year":"2011","unstructured":"Cayla, G. et al. Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis. JAMA 306, 1765\u20131774. https:\/\/doi.org\/10.1001\/jama.2011.1529 (2011).","journal-title":"JAMA"},{"key":"50920_CR16","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","volume":"36","author":"D Aradi","year":"2015","unstructured":"Aradi, D. et al. Bleeding and stent thrombosis on P2Y12-inhibitors: Collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur. Heart J. 36, 1762\u20131771. https:\/\/doi.org\/10.1093\/eurheartj\/ehv104 (2015).","journal-title":"Eur. Heart J."},{"key":"50920_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1161\/circulationaha.110.981688","volume":"123","author":"GD Dangas","year":"2011","unstructured":"Dangas, G. D. et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123, 1745\u20131756. https:\/\/doi.org\/10.1161\/circulationaha.110.981688 (2011).","journal-title":"Circulation"},{"key":"50920_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"JW Suh","year":"2011","unstructured":"Suh, J. W. et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: Results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. J. Am. Coll. Cardiol. 57, 280\u2013289. https:\/\/doi.org\/10.1016\/j.jacc.2010.08.631 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50920_CR19","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.jcin.2022.09.007","volume":"15","author":"SJ Lee","year":"2022","unstructured":"Lee, S. J. et al. Platelet reactivity and clinical outcomes after drug-eluting stent implantation: Results from the PTRG-DES consortium. JACC Cardiovasc. Interv. 15, 2253\u20132265. https:\/\/doi.org\/10.1016\/j.jcin.2022.09.007 (2022).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","volume":"12","author":"D Sibbing","year":"2019","unstructured":"Sibbing, D. et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc. Interv. 12, 1521\u20131537. https:\/\/doi.org\/10.1016\/j.jcin.2019.03.034 (2019).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"D Trenk","year":"2012","unstructured":"Trenk, D. et al. A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J. Am. Coll. Cardiol. 59, 2159\u20132164. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.026 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"50920_CR22","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","volume":"388","author":"G Cayla","year":"2016","unstructured":"Cayla, G. et al. Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): An open-label, blinded-endpoint, randomised controlled superiority trial. Lancet 388, 2015\u20132022. https:\/\/doi.org\/10.1016\/S0140-6736(16)31323-X (2016).","journal-title":"Lancet"},{"key":"50920_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","volume":"5","author":"EJ Armstrong","year":"2012","unstructured":"Armstrong, E. J. et al. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc. Interv. 5, 131\u2013140. https:\/\/doi.org\/10.1016\/j.jcin.2011.10.013 (2012).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1161\/CIRCINTERVENTIONS.108.794578","volume":"1","author":"LO Jensen","year":"2008","unstructured":"Jensen, L. O. et al. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction. Circ. Cardiovasc. Interv. 1, 176\u2013184. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.108.794578 (2008).","journal-title":"Circ. Cardiovasc. Interv."},{"key":"50920_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcin.2009.04.003","volume":"2","author":"N Kukreja","year":"2009","unstructured":"Kukreja, N. et al. The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents. JACC Cardiovasc. Interv. 2, 534\u2013541. https:\/\/doi.org\/10.1016\/j.jcin.2009.04.003 (2009).","journal-title":"JACC Cardiovasc. Interv."},{"key":"50920_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5114\/pwki.2014.46761","volume":"10","author":"P Tyczynski","year":"2014","unstructured":"Tyczynski, P., Karcz, M. A., Kalinczuk, L., Fronczak, A. & Witkowski, A. Early stent thrombosis. Aetiology, treatment, and prognosis. Postepy Kardiol. Interwencyjnej 10, 221\u2013225. https:\/\/doi.org\/10.5114\/pwki.2014.46761 (2014).","journal-title":"Postepy Kardiol. Interwencyjnej"},{"key":"50920_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1055\/s-0040-1718729","volume":"121","author":"HK Kim","year":"2021","unstructured":"Kim, H. K. et al. The east Asian paradox: An updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost 121, 422\u2013432. https:\/\/doi.org\/10.1055\/s-0040-1718729 (2021).","journal-title":"Thromb Haemost"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50920-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50920-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:16:59Z","timestamp":1704356219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-50920-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50920"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-50920-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"520"}}